MicroRNA-9 enhances sensitivity to cetuximab in epithelial phenotype hepatocellular carcinoma cells through regulation of the eukaryotic translation initiation factor 5A-2

Hepatocellular carcinoma (HCC) is one of the most widespread malignant human tumors worldwide. Treatment options include radiotherapy, surgical intervention and chemotherapy; however, drug resistance is an ongoing treatment concern. In the present study, the effects of a microRNA (miR/miRNA), miR-9,...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Fei, Liang, Yuntian, Li, Zhenrong, Liu, Yanhui, Zhang, Hongwei, Wen, Yu, Yan, Lei, Tang, Qiang, Xiao, Erhui, Zhang, Dongyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772877/
https://www.ncbi.nlm.nih.gov/pubmed/29399149
http://dx.doi.org/10.3892/ol.2017.7399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772877/
https://www.ncbi.nlm.nih.gov/pubmed/29399149
http://dx.doi.org/10.3892/ol.2017.7399

Ejemplares similares